Bethany Sensenig - 18 Jan 2022 Form 4 Insider Report for 9 METERS BIOPHARMA, INC.

Role
Chief Financial Officer
Signature
/s/ Lorna A. Knick, as power of attorney
Issuer symbol
N/A
Transactions as of
18 Jan 2022
Net transactions value
$0
Form type
4
Filing time
18 Jan 2022, 18:24:35 UTC
Previous filing
18 Jan 2022
Next filing
29 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NMTR Stock Option (Right to Buy) Award $0 +1,300,000 $0.000000 1,300,000 18 Jan 2022 Common stock 1,300,000 $0.8449 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of these shares shall be deemed vested and exercisable on January 18, 2023 with the remainder vesting in equal monthly installments over the next 36 months, such that the option shall be fully vested on January 18, 2026, subject to the executive's continued service with the Company through each applicable vesting date.